Phosphodiester Oligonucleotides Inhibit Mitosis and Trigger Apoptosis by a Non-Antisense, p53-Mediated Mechanism
- 1 February 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 12 (1) , 21-31
- https://doi.org/10.1089/108729002753670238
Abstract
Oligodeoxyribonucleotides (ODNs) are currently employed to switch-off genes selectively routinely in the laboratory practice. The drawback of ODN application is that they have been often reported to elicit non-antisense effects by different mechanisms. Recently, it has been shown that double-stranded DNA oligonucleotides (30-mers) with protruding ends activate p53 in a cell-free system. In a previous work, we described that simple addition to the culture medium of heterogeneous DNA combined with cationic lipids culminated in inhibition of mitosis and induction of apoptosis. Here, we report that the same effects are achieved by lipotransfecting cultured cells with phosphorodiester ODNs (30-mers). Such effects of ODN were mediated by a non-antisense mechanism that required the wild-type form of the p53 oncosuppressor protein and was dependent on ODN concentration. Mitosis inhibition and apoptosis induction appeared to be determined by the 3′ and 5′ free ends of ODNs, which activated p53 independently from their sequence. Most probably, this mechanism is analogous to that evoked by genotoxic agent-induced DNA damage or by lipotransfecting cells with heterogeneous DNA.Keywords
This publication has 40 references indexed in Scilit:
- Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-α production through activation of NF-κBInternational Immunology, 2001
- From Bugs to Drugs: Therapeutic Immunomodulation with Oligodeoxynucleotides Containing CpG Sequences from Bacterial DNAAntisense and Nucleic Acid Drug Development, 2001
- Direct Immunologic activities of CpG DNA and implications for gene therapyThe Journal of Gene Medicine, 1999
- Therapeutic Applications of CpG-Containing OligodeoxynucleotidesAntisense and Nucleic Acid Drug Development, 1998
- p53 in growth control and neoplasiaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Activation of p53 sequence-specific DNA bindingby short single strands of DNA requires the p53 C-terminusCell, 1995
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Allosteric activation of latent p53 tetramersCurrent Biology, 1994
- Cationic Lipids Improve Antisense Oligonucleotide Uptake and Prevent Degradation in Cultured Cells and in Human SerumBiochemical and Biophysical Research Communications, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992